Variable | RMP Method | OAD Method | Total | PValue |
---|---|---|---|---|
No. | 40 | 45 | 85 | |
Pretreatment NIHSS score | 16 (11–21) | 17 (12–21) | 16 (12–21) | .832a |
Time to treatment (min) | 298 (178–347) | 248 (204–304) | 270 (202–328) | .199a |
Median age (yr) | 68 (59–75) | 68 (54–76) | 68 (56–75) | .689a |
Female sex (%) | 12 (30.0%) | 23 (51.1%) | 35 (41.2%) | .0484b |
History of diabetes | 10 (25.0%) | 7 (15.6%) | 17 (20.0%) | .277b |
Systolic blood pressure | 148 (134–169) | 140 (129–169) | 147 (130–169) | .764a |
Admitting glucose value | 127 (111–173) | 113 (100–133) | 121 (103–146) | .0342a |
Admitting platelet level | 228 (194–256) | 216 (180–276) | 225 (186–264) | .986a |
Hematocrit level | 39.9 (36.3–42.9) | 39.1 (34.1–43.8) | 39.6 (35.1–43.1) | .506a |
Slow antegrade flow | 11 (27.5%) | 12 (26.7%) | 23 (27.1%) | .931b |
Good pial collaterals | 31 (77.5%) | 34 (75.6%) | 65 (76.5%) | .833b |
% proximal occlusion | 30 (72.5%) | 37 (82.2%) | 66 (77.6%) | .283b |
Location | ||||
ICA | 4 (10.0%) | 8 (17.8%) | 12 (14.1%) | .531b |
MCA | 33 (82.5%) | 32 (71.1%) | 65 (76.5%) | |
ACA | 0 (0%) | 1 (2.33%) | 1 (1.2%) | |
BA | 3 (7.50%) | 4 (8.89%) | 7 (8.24%) |